Publications

• 07.10.2026  |  Defining a target product profile for antimicrobials to treat severe paediatric bacterial enteric infections in low- and medium-income countries, caused by E. coli, Shigella, Salmonella and Campylobacter species Download
• 07.02.2026  |  An evaluation of the US public–private Combating Antibiotic-Resistant Bacteria Accelerator (CARB-X) initiative Download
• 06.02.2026  |  Considerations in Designing Clinical Trials of Novel Antibacterial Agents Using a Superiority Design Download
• 03.20.2026  |  Diagnostics for priority bacterial pathogens: global gaps and research needs for curbing antimicrobial resistance in low-resource settings Download
• 03.20.2026  |  When the whole exceeds the sum of its parts: Squeezing greater cumulative benefit from cross-technology partnerships in bacterial infection Download
• 02.19.2026  |  Vaccines and antimicrobial resistance: from science to policy-summary and outcomes Download
• 02.18.2026  |  Current infection control practices for multidrug-resistant organisms (MDRO): a survey of the Society for Healthcare Epidemiology of America (SHEA) research network and affiliated US-based hospitals Download
• 12.02.2025  |  Social science contributions to the global action plan on antimicrobial resistance Download
• 10.07.2025  |  A One Health framework for global and local stewardship across the antimicrobial lifecycle Download
• 09.08.2025  |  Bridging the fair share gap for antibacterial innovation: an observational analysis of antibacterial revenues in the G7 and EU27 Download
• 07.30.2025  |  De-risking vaccine development: lessons, challenges, and prospects Download
• 07.02.2025  |  Infection risk associated with colonization by multidrug-resistant Gram-negative bacteria: An umbrella review and meta-analysis Download
• 04.30.2025  |  The antimicrobial resistance cube: a framework for identifying policy gaps and driving action Download
• 04.14.2025  |  The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance Download
• 03.27.2025  |  Quantitative performance of humanized plasma and epithelial lining fluid exposures of meropenem, cefiderocol and tobramycin against a challenge set of Klebsiella pneumoniae and Pseudomonas aeruginosa in a standardized neutropenic murine pneumonia model Download